Moleculin Biotech
MBRX
MBRX
21 hedge funds and large institutions have $2.91M invested in Moleculin Biotech in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$156K | |
| 2 | +$46.6K | |
| 3 | +$32.2K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.9K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$10K |
Top Sellers
| 1 | -$137K | |
| 2 | -$88K | |
| 3 | -$65K | |
| 4 |
Morgan Stanley
New York
|
-$32K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$16K |